A possible deal could expand Tevogen’s healthcare infrastructure; a services arm would depend on proposed transactions.

UPDATE – Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of HRK Healthcare LLC

WARREN, N.J., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Tevogen Inc. (“Tevogen” or the “Company”) (Nasdaq: TVGN ), an integrated healthcare enterprise combining biopharma, artificial intelligence, and healthcare services to improve the affordability and accessibility of life-saving medicines, today announced that…

A possible deal could expand Tevogen’s healthcare infrastructure; a services arm would depend on proposed transactions.

The HRK proposal and other acquisition initiatives could potentially put Tevogen on a path to about $100 million in combined annual revenue.